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NMR and MS spectra of compounds. F1 . 1 F12. ESI-MS spectrum of Diol3o3-dPxTP.
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. 1 H NMR (300 MHz, D 2 O) spectrum of DMP-hx-dPxTP.
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. 31 P NMR (121 MHz, D 2 O) spectrum of DMP-hx-dPxTP.
F15. ESI-MS spectrum of DMP-hx-dPxTP.
F16
. 1 H NMR (300 MHz, D 2 O) spectrum of NTP-hx-dPxTP.
F17
. 31 P NMR (121 MHz, D 2 O) spectrum of NTP-hx-dPxTP.
F18. ESI-MS spectrum of NTP-hx-dPxTP.
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. 1 H NMR (300 MHz, D 2 O) spectrum of BPh-hx-dPxTP.
F20
. 31 P NMR (121 MHz, D 2 O) spectrum of BPh-hx-dPxTP.
F21. ESI-MS spectrum of BPh-hx-dPxTP.
F22
. 1 H NMR (300 MHz, D 2 O) spectrum of HBP-hx-dPxTP.
F23
. 31 P NMR (121 MHz, D 2 O) spectrum of HBP-hx-dPxTP.
F24. ESI-MS spectrum of HBP-hx-dPxTP.
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Biological experimental methods and data. b >97% is the maximum detection limit by the assessment.
S5

Analysis of the retention rates of the Ds-Px pair in the PCR-amplified DNAs
We calculated the retention rates of the Ds-Px pair in the amplified DNA fragments, by sequencing the DNA fragments in the presence of ddPa′TP and comparing the sequencing peak patterns with those of authentic DNA samples ( Figures S1 and S2 ). For authentic sequencing data, we used a DNA fragment 
Chemical synthesis of dPxTP
S15
saturated aqueous NaCl, dried with Na 2 SO 4 , and evaporated in vacuo. The residue was subjected to silica gel column chromatography, using 0.5% methanol in CH 2 Cl 2 as an eluent, to afford 365 mg of
0.28 mmol) was coevaporated to dryness with pyridine three times. To the residue in pyridine (2.8 ml), acetic anhydride (53 μl, 0.56 mmol) was added. The reaction mixture was stirred at room temperature for 12 h and was extracted by ethyl acetate and 5% aqueous NaHCO 3 . The organic phase was dried with Na 2 SO 4 and evaporated in vacuo. The residue was coevaporated to dryness with toluene. To the residue in CH 2 Cl 2 (28 ml) was added dichloroacetic acid (280 μl) at 0°C. The reaction mixture was stirred at 0°C for 15 min. To the reaction mixture was added 5% aqueous NaHCO 3 , and the organic phase was washed with 5% NaHCO 3 and saturated NaCl. After drying over Na 2 SO 4 , the solvent was evaporated in vacuo. The residue was subjected to silica gel column chromatography to afford 78 mg (89%) of 
1-(2-Deoxy-β-D-ribofuranosyl)-4-propynyl-2-nitropyrrole 5'-triphosphate (dPxTP).
1-(2-Deoxy-3-O-acetyl-β-D-ribofuranosyl)-4-propynyl-2-nitropyrrole (31 mg, 0.1 mmol) was coevaporated with pyridine to dryness. The residue was dissolved in pyridine (100 μl) and dioxane (300 μl). A 1 M solution of 2-chloro-1,3,2-benzodioxaphosphorin-4-one in dioxane (110 μl, 0.11 mmol) was added. After 10 min, tri-n-butylamine (100 μl) and 0.5 M bis(tributylammonium)pyrophosphate in DMF (300 μl, 0.15 mmol) were added to the reaction mixture, which was stirred at room temperature for 10 min. A solution of 1% iodine in pyridine/water (98:2, v/v, 2.0 ml) was added. After 15 min, a 5% aqueous solution of NaHSO 3 (150 μl), followed by water (5 ml) was added to the reaction mixture, which was stirred at room temperature for 30 min, and then 28% NH 4 OH (20 ml) was added.
S16
Ammonolysis was performed at room temperature for 2 h. After the reaction mixture was concentrated in vacuo, the product was purified by DEAE Sephadex ( 
Chemical synthesis of NH 2 -C1-dPxTP
Conditions; (a) 1-(2-deoxy--D-ribofuranosyl)-4-iodo-2-nitropyrrole, TFA-NH-linker, CuI, I-dPn, Pd(PPh 3 ) 4 , DMF (b) (i) POCl 3 , proton sponge, tri-n-butylamine, bis(tributylammonium)pyrophosphate (ii) 28% NH 4 OH
1-(2-Deoxy-β-D-ribofuranosyl)-4-[3-(trifluoroacetamido)-1-propynyl]-2-nitropyrrole (TFA-NH-C1-dPx).
A solution of aceticanhydride (4.6 ml, 33 mmol) in CH 2 Cl 2 (30 ml) was added to a solution of propargylamine (1.0 ml, 15 mmol), CH 2 Cl 2 (30 ml), and pyridine (3.7 ml) at 0℃.
The reaction mixture was stirred at room temperature for 12 h. The product was extracted with CH 2 Cl 2 /5% NaHCO 3 , and the organic phase was washed with 5% NaHCO 3 , and dried with Na 2 SO 4 .
The 
Chemical synthesis of Diol3o3-dPxTP
5-(4-Pentynyloxy)pentane-1,2-diacetate (Di(OAc)3o3 linker).
A mixture of 4-pentyne-1-ol (4.65 ml, 50 mmol), 5-bromo-1-pentene (17.8 ml, 150 mmol), and KOH (12.6 g, 225 mmol) in benzene (50 ml) was refluxed for 12 h. After filtration, the reaction mixture was separated with ethyl acetate and 10% NH 4 Cl. The organic phase was washed with 10% NH 4 Cl and saturated NaCl, dried with Na 2 SO 4 , and evaporated in vacuo. The product was purified by silica gel chromatography (eluted with 10% EtOAc in hexane) to give 6.5 g of crude 5-(4-pentynyloxy)-1-pentene. OsO 4 (543 mg, 2.0 mmol) was added to a solution of crude 5-(4-pentynyloxy)-1-pentene (6.5 g) and N-methylmorpholine-N-oxide (10.0 g, 85.4 mmol) in acetone/H 2 O/tBuOH (4:1:1, 214 ml). The reaction mixture was stirred at room temperature for 1 h. NaHSO 3 (1.5 g) was then added to the reaction mixture. After the resulting precipitate was removed by filtration and washed with MeOH, the filtered solution was concentrated in vacuo. The product was purified by silica gel column chromatography (eluted with 3% MeOH in CH 2 Cl 2 ) to give crude 5-(4-pentynyloxy)pentane-1,2-diol (2.9 g). After the crude 5-(4-pentynyloxy)pentane-1,2-diol (2.9 g) was co-evaporated with pyridine, acetic anhydride (5.9 ml, 62.4 mmol) was added to the crude diol in 
1-(2-Deoxy-β-D-ribofuranosyl)-4-[5-(4-pentynyloxy
1-(2-Deoxy-β-D-ribofuranosyl)-4-[5-(4-pentynyloxy)pentane-1,2-diol)-1-propynyl]-2-nitropyrrole 5'-triphosphate (Diol3o3-dPxTP).
A di(OAc)3o3-dPx nucleoside (50 mg, 0.1 mmol) was evaporated to dryness with pyridine and toluene, and the nucleoside and a proton sponge (33 mg, 0.15 mmol) were dissolved in (CH 3 O) 3 PO (500 l). POCl 3 (13 l, 0.13 mmol) was added to the solution at 0 °C. After the reaction mixture was stirred at 0°C for 1.5 h, tri-n-butylamine (120 l) and bis-tri-n-butylammonium pyrophosphate (1.0 ml, 0.5 M DMF solution) were added to the reaction mixture. After 30 min, 500 l of 0.5 M triethylamine bicarbonate and water (5.0 ml) were added to the reaction mixture, which was stirred at 0°C for 30 min. After lyophilization, the compound in H 2 O (2.0 ml) was treated with 28%
NH 4 OH at room temperature for 1h. After the volatile components were removed, the product was purified by DEAE Sephadex A-25 ion exchange column chromatography (eluted with a linear gradient of 50 mM to 1.0 M TEAB) and RP-HPLC (5-50% CH 3 CN in 100 mM TEAA, 12 min) to give 18 mol (18%) of Diol3o3-dPxTP. in DMF (3.0 ml) and triethylamine (6.2 µl) at room temperature. After 24 h, the reaction mixture was diluted with H 2 O (18 ml) and filtered using a Steriflip (Millipore) to remove the precipitate thus generated. The filtrate was lyophilized, and then dissolved in TEAA buffer (2 ml). The product (15.4 µmol, 51%) was purified by C18 reverse phase column chromatography (Nacalai COSMOSIL 
Chemical synthesis of NTP-hx-dPxTP.
1-Naphthoic acid N-hydroxysuccinimidyl ester. 1-Naphthoic acid (176 mg, 1.02 mmol), N-hydroxysuccinimide (174 mg, 1.51 mmol) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (288 mg, 1.50 mmol) were dissolved in dry CH 2 Cl 2 (5 ml) and stirred at room temperature for 18 h. The reaction mixture was extracted with CH 2 Cl 2 (10 ml) and washed with an aqueous solution of saturated NaHCO 3 (10 ml) and brine (10 ml). The organic phase was dried over Na 2 SO 4 , and 
Naphthalene-modified dPxTP (NTP-hx-dPxTP). A solution of NH 2 -hx-dPxTP (30 µmol) in 40%
DMF-H 2 O (3.0 ml) was reacted with 1-naphthoic acid N-hydroxysuccinimidyl ester (120 µmol) in DMF (3.0 ml) and triethylamine (6.2 µl) at room temperature. After 66 h, the reaction mixture was diluted with H 2 O (18 ml) and filtered using a Steriflip (Millipore) to remove the precipitate thus generated. The filtrate was lyophilized, and then dissolved in TEAA buffer (3 ml). The product (16.4 µmol, 55%) was purified by C18 reverse phase column chromatography (Nacalai COSMOSIL 140C19-OPN, eluted by a 
Biphenyl-modified dPxTP (BPH-hx-dPxTP).
A solution of NH 2 -hx-dPxTP (30 µmol) in 40%
DMF-H 2 O (3.0 ml) was reacted with 4-biphenylcarboxylic acid N-hydroxysuccinimidyl ester (120 µmol) in DMF (3.0 ml) and triethylamine (6.2 µl) at room temperature. After 51 h, the reaction mixture was diluted with H 2 O (18 ml) and filtered using a Steriflip (Millipore) to remove the precipitate thus generated. The filtrate was lyophilized, and then dissolved in TEAA buffer (3 ml). The product (10.0 µmol, 33%) was purified by C18 reverse phase column chromatography (Nacalai COSMOSIL 
4-hydroxybiphenyl-modified dPxTP (HBP-hx-dPxTP).
A solution of NH 2 -hx-dPxTP (30 µmol) in 40% DMF-H 2 O (3.0 ml) was reacted with 4'-hydroxy-4-biphenylcarboxylic acid N-hydroxysuccinimidyl ester (120 µmol) in DMF (3.0 ml) and triethylamine (6.2 µl) at room temperature. After 45 h, the reaction mixture was diluted with H 2 O (18 ml) and filtered using a Steriflip (Millipore) to remove the precipitate thus generated. The filtrate was lyophilized, and then dissolved in TEAA buffer (2 ml). The product (13.9 µmol, 46%) was purified by C18 reverse phase column chromatography (Nacalai COSMOSIL 140C19-OPN, eluted by a linear gradient of 0-30% CH 3 CN in 100 mM TEAA, pH 7.0) and 
